<VariationArchive VariationID="4519" VariationName="NM_006005.3(WFS1):c.409_424dup (p.Val142fs)" VariationType="Duplication" Accession="VCV000004519" Version="24" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-07-29" DateCreated="2015-07-30" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19558" VariationID="4519">
      <GeneList>
        <Gene Symbol="WFS1" FullName="wolframin ER transmembrane glycoprotein" GeneID="7466" HGNC_ID="HGNC:12762" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4p16.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="6269850" stop="6303265" display_start="6269850" display_stop="6303265" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="6271576" stop="6304991" display_start="6271576" display_stop="6304991" Strand="+" />
          </Location>
          <OMIM>606201</OMIM>
          <Haploinsufficiency last_evaluated="2012-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=WFS1">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=WFS1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006005.3(WFS1):c.409_424dup (p.Val142fs)</Name>
      <CanonicalSPDI>NC_000004.12:6289078:GGGCCGTCGCGAGGCTG:GGGCCGTCGCGAGGCTGGGCCGTCGCGAGGCTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4p16.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="6289078" stop="6289079" display_start="6289078" display_stop="6289079" variantLength="16" positionVCF="6289078" referenceAlleleVCF="A" alternateAlleleVCF="AGGGCCGTCGCGAGGCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="6290805" stop="6290806" display_start="6290805" display_stop="6290806" variantLength="16" positionVCF="6290805" referenceAlleleVCF="A" alternateAlleleVCF="AGGGCCGTCGCGAGGCT" />
      </Location>
      <ProteinChange>V142fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.6290807_6290822dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.6290807_6290822dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.6289080_6289095dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.6289080_6289095dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011700.1" sequenceAccession="NG_011700" sequenceVersion="1" change="g.24231_24246dup">
            <Expression>NG_011700.1:g.24231_24246dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145853.1" sequenceAccession="NM_001145853" sequenceVersion="1" change="c.409_424dup">
            <Expression>NM_001145853.1:c.409_424dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001139325.1" sequenceAccession="NP_001139325" sequenceVersion="1" change="p.Val142fs">
            <Expression>NP_001139325.1:p.Val142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006005.3" sequenceAccession="NM_006005" sequenceVersion="3" change="c.409_424dup" MANESelect="true">
            <Expression>NM_006005.3:c.409_424dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005996.2" sequenceAccession="NP_005996" sequenceVersion="2" change="p.Val142fs">
            <Expression>NP_005996.2:p.Val142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1417" sequenceAccession="LRG_1417">
            <Expression>LRG_1417:g.24231_24246dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1417t1" sequenceAccession="LRG_1417t1">
            <Expression>LRG_1417t1:c.409_424dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1417p1" sequenceAccession="LRG_1417p1" change="p.Val142fs">
            <Expression>LRG_1417p1:p.Val142fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006005.3" sequenceAccession="NM_006005" sequenceVersion="3" change="c.409_424dupGGCCGTCGCGAGGCTG" MANESelect="true">
            <Expression>NM_006005.3:c.409_424dupGGCCGTCGCGAGGCTG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA253196" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606201.0013" DB="OMIM" />
        <XRef Type="rs" ID="1362648752" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006005.3(WFS1):c.409_424dup (p.Val142fs) AND Wolfram syndrome 1" Accession="RCV000004777" Version="15">
        <ClassifiedConditionList TraitSetID="1243">
          <ClassifiedCondition DB="MedGen" ID="C4551693">Wolfram syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-10-25" SubmissionCount="4">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006005.3(WFS1):c.409_424dup (p.Val142fs) AND Wolfram syndrome" Accession="RCV000499974" Version="8">
        <ClassifiedConditionList TraitSetID="13180">
          <ClassifiedCondition DB="MedGen" ID="C0043207">Wolfram syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-03-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006005.3(WFS1):c.409_424dup (p.Val142fs) AND WFS1-Related Spectrum Disorders" Accession="RCV000778736" Version="7">
        <ClassifiedConditionList TraitSetID="33712">
          <ClassifiedCondition DB="MedGen" ID="CN239410">WFS1-Related Spectrum Disorders</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-01-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006005.3(WFS1):c.409_424dup (p.Val142fs) AND not provided" Accession="RCV001385126" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-12-28" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006005.3(WFS1):c.409_424dup (p.Val142fs) AND Type 2 diabetes mellitus" Accession="RCV001542530" Version="5">
        <ClassifiedConditionList TraitSetID="1517">
          <ClassifiedCondition DB="MedGen" ID="C0011860">Type 2 diabetes mellitus</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-28" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2015-07-30" MostRecentSubmission="2024-03-10">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11161832</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1161832</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12955714</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15151504</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21446023</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21602428</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22238590</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23429432</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26875006</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32141364</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-10">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="33712" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36607" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">WFS1-Related Spectrum Disorders</ElementValue>
                <XRef ID="819783" DB="Illumina Laboratory Services, Illumina" />
              </Name>
              <XRef ID="CN239410" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1517" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4949" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Type II diabetes mellitus</ElementValue>
                <XRef ID="HP:0005978" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Type 2 diabetes mellitus</ElementValue>
                <XRef ID="Diabetes+mellitus+type+2/8215" DB="Genetic Alliance" />
                <XRef ID="HP:0005978" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005148" DB="MONDO" />
                <XRef ID="44054006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST</ElementValue>
                <XRef ID="125853" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diabetes mellitus, noninsulin-dependent, late onset</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NIDDM</ElementValue>
                <XRef ID="HP:0005978" DB="Human Phenotype Ontology" />
                <XRef Type="MIM" ID="125853" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">T2D</ElementValue>
                <XRef Type="MIM" ID="125853" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301750</ID>
                <ID Source="BookShelf">NBK4144</ID>
              </Citation>
              <Citation Type="general" Abbrev="PLoS Currents, 2011">
                <URL>http://knol.google.com/k/raluca-mihaescu/genetic-risk-profiling-for-prediction/20113liwenx5c/9?collectionId=28qm4w0q65e4w.50#</URL>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2013">
                <ID Source="PubMed">23492873</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2012">
                <ID Source="PubMed">22962670</ID>
                <ID Source="pmc">3431581</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg181</URL>
                <CitationText>UK NICE Guidance, Clinical Guideline CG181, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng18</URL>
                <CitationText>UK NICE Guideline NG18, Diabetes (type 1 and type 2) in children and young people: diagnosis and management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng28</URL>
                <CitationText>UK NICE Guideline NG28, Type 2 diabetes in adults: management, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng136</URL>
                <CitationText>UK NICE Guideline NG136, Hypertension in adults: diagnosis and management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/ng3</URL>
                <CitationText>UK NICE Guideline NG3, Diabetes in pregnancy: management from preconception to the postnatal period</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/ng19</URL>
                <CitationText>UK NICE Guideline NG19, Diabetic foot problems: prevention and management, 2019</CitationText>
              </Citation>
              <XRef ID="C0011860" DB="MedGen" />
              <XRef ID="D003924" DB="MeSH" />
              <XRef ID="MONDO:0005148" DB="MONDO" />
              <XRef Type="MIM" ID="125853" DB="OMIM" />
              <XRef Type="primary" ID="HP:0005978" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005965" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0100652" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13180" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18587" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Diabetes mellitus AND insipidus with optic atrophy AND deafness</ElementValue>
                <XRef ID="Diabetes+mellitus+AND+insipidus+with+optic+atrophy+AND+deafness/8213" DB="Genetic Alliance" />
                <XRef ID="70694009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DIDMOAD syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wolfram syndrome</ElementValue>
                <XRef ID="MONDO:0018105" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DIDMOAD</ElementValue>
                <XRef Type="MIM" ID="222300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WFS</ElementValue>
                <XRef Type="MIM" ID="222300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">WFS1 Wolfram syndrome spectrum disorder (WFS1-WSSD) is a progressive neurodegenerative disorder characterized by onset of diabetes mellitus (DM) and optic atrophy (OA) before age 16 years, and typically associated with other endocrine abnormalities, sensorineural hearing loss, and progressive neurologic abnormalities (cerebellar ataxia, peripheral neuropathy, dementia, psychiatric illness, and urinary tract atony). Although DM is mostly insulin-dependent, overall the course is milder (with lower prevalence of microvascular disease) than that seen in isolated DM. OA typically results in significantly reduced visual acuity in the first decade. Sensorineural hearing impairment ranges from congenital deafness to milder, sometimes progressive, hearing impairment.</Attribute>
                <XRef ID="NBK4144" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7898" />
                <XRef ID="7898" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301607</ID>
                <ID Source="BookShelf">NBK1434</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301750</ID>
                <ID Source="BookShelf">NBK4144</ID>
              </Citation>
              <XRef ID="3463" DB="Orphanet" />
              <XRef ID="C0043207" DB="MedGen" />
              <XRef ID="MONDO:0018105" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1243" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3970" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Wolfram syndrome 1</ElementValue>
                <XRef ID="MONDO:0009101" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WFS1</ElementValue>
                <XRef ID="GTR000522537" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="222300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">WFS1 Wolfram syndrome spectrum disorder (WFS1-WSSD) is a progressive neurodegenerative disorder characterized by onset of diabetes mellitus (DM) and optic atrophy (OA) before age 16 years, and typically associated with other endocrine abnormalities, sensorineural hearing loss, and progressive neurologic abnormalities (cerebellar ataxia, peripheral neuropathy, dementia, psychiatric illness, and urinary tract atony). Although DM is mostly insulin-dependent, overall the course is milder (with lower prevalence of microvascular disease) than that seen in isolated DM. OA typically results in significantly reduced visual acuity in the first decade. Sensorineural hearing impairment ranges from congenital deafness to milder, sometimes progressive, hearing impairment.</Attribute>
                <XRef ID="NBK4144" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301750</ID>
                <ID Source="BookShelf">NBK4144</ID>
              </Citation>
              <XRef ID="3463" DB="Orphanet" />
              <XRef ID="C4551693" DB="MedGen" />
              <XRef ID="MONDO:0009101" DB="MONDO" />
              <XRef Type="MIM" ID="222300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1154433" SubmissionDate="2017-07-05" DateLastUpdated="2017-08-28" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="NM_006005.3(WFS1):c.409_424dup|Wolfram syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000597979" DateUpdated="2017-08-28" DateCreated="2017-08-28" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WFS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006005.3:c.409_424dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Wolfram syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2843028</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790165" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="850977" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915094" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23429432</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21446023</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15151504</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21602428</ID>
          </Citation>
          <Comment>Across a selection of available literature, the WFS1 c.409_424dupGGCCGTCGCGAGGCTG (p.Val142GlyfsTer110) variant has been identified in in seven individuals with Wolfram syndrome, including in a homozygous state in four individuals from three families and in a compound heterozygous state in three unrelated individuals (Domenech et al. 2004; Chaussenot et al. 2011; Rohayem et al. 2011). A systematic review of disease-causing variants associated with Wolfram syndrome indicated that the p.Val142GlyfsTer110 variant is present in 6.53% of patients and is a common cause of Wolfram syndrome in the Spanish population (de Heredia et al. 2013; Domenech et al. 2004). The variant was absent from 98 control chromosomes and is reported at a frequency of 0.000103 in the Latino population of the Genome Aggregation Database. Based on the collective evidence, the p.Val142GlyfsTer110 variant is classified as pathogenic for WFS1-related spectrum disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WFS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="4" alternateAllele="AGGGCCGTCGCGAGGCT" referenceAllele="A" start="6290805" stop="6290805" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006005.3:c.409_424dupGGCCGTCGCGAGGCTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WFS1-Related Spectrum Disorders</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN239410" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3110526" SubmissionDate="2023-01-06" DateLastUpdated="2023-02-07" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4666330|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001584880" DateUpdated="2023-02-07" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12955714</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1161832</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26875006</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32141364</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val142Glyfs*110) in the WFS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in WFS1 are known to be pathogenic (PMID: 12955714). This variant is present in population databases (rs767046229, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with autosomal recessive Wolfram syndrome (PMID: 1161832, 26875006, 32141364). This variant is also known as 425ins16. ClinVar contains an entry for this variant (Variation ID: 4519). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WFS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.6290805_6290806insGGGCCGTCGCGAGGCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="24953" SubmissionDate="2015-07-27" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606201.0013_WOLFRAM SYNDROME 1" title="WFS1, 16-BP DUP, NT409_WOLFRAM SYNDROME 1" />
        <ClinVarAccession Accession="SCV000024953" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Gomez-Zaera et al. (2001) studied 22 Wolfram syndrome (WFS1; 222300) patients from 16 Spanish families for mutations in the WFS1 coding region by SSCP analysis and direct sequencing. Fifty percent of the pedigrees were found to have a single mutation, 67% in homozygosity and 33% in compound heterozygosity. The authors stated that the mutation is a 16-bp insertion in exon 4 at nucleotide 425 and is predicted to produce an aberrant protein; assuming that no splicing alterations occur, translation will follow until residue 251, where a stop codon is created. The high incidence of this mutation in Spanish families may be explained by a founder effect.</Attribute>
              <Citation>
                <CitationText>Gomez-Zaera, M., Strom, T. M., Rodriguez, B., Estivill, X., Meitinger, T., Nunes, V. Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Molec. Genet. Metab. 72: 72-81, 2001.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="222300" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 4 patients from 3 Spanish families with Wolfram syndrome, Domenech et al. (2004) identified the 425ins16 mutation, which they referred to as a 16-bp duplication (409dup16).</Attribute>
              <Citation>
                <CitationText>Domenech, E., Gomez-Zaera, M., Nunes, V. Study of the WFS1 gene and mitochondrial DNA in Spanish Wolfram syndrome families. Clin. Genet. 65: 463-469, 2004.</CitationText>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WFS1" />
          </GeneList>
          <Name>WFS1, 16-BP DUP, NT409</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">16-BP DUP, NT409</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606201.0013" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WOLFRAM SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3463178" SubmissionDate="2021-07-15" DateLastUpdated="2021-07-27" DateCreated="2021-07-27">
        <ClinVarSubmissionID localKey="NC_000004.11:g.6290807_6290822dup|OMIM:125853" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001760140" DateUpdated="2021-07-27" DateCreated="2021-07-27" Type="SCV" Version="1" SubmitterName="Genomics England Pilot Project, Genomics England" OrgID="508170" OrganizationCategory="laboratory" OrgAbbreviation="GeL_Pilot" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACGS Guidelines, 2016</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ylgat5th/acgs_best_practice_guidelines_for_variant_classification_in_rare_disease_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.6290807_6290822dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="125853" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10010620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3820372" SubmissionDate="2021-09-28" DateLastUpdated="2021-09-29" DateCreated="2021-09-29">
        <ClinVarSubmissionID localKey="SUB10388078" submittedAssembly="GRCh37" title="SUB10388078" />
        <ClinVarAccession Accession="SCV001943369" DateUpdated="2021-09-29" DateCreated="2021-09-29" Type="SCV" Version="1" SubmitterName="Breda Genetics srl" OrgID="506812" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">23429432</ID>
          </Citation>
          <Comment>The variant c.409_424dup (p.Val142Glyfs*110) in the WFS1 gene is reported as pathogenic for Wolfram syndrome 1 and WFS1-related spectrum disorders in ClinVar (Variation ID: 4519), and as pathogenic in the Global Variome shared LOVD database v.3.0. It creates a shift in the reading frame, which is predicted to result in a premature stop codon 110 amino acids downstream and in a truncated protein or protein loss due to nonsense-mediated messenger decay (NMD). The variant is reported with an estimated allele frequency of 0.0000439 in gnomAD exomes, with no homozygous individuals reported. According to the systematic review conducted by De Heredia et al. (2013) about disease-causing mutations in 412 patients with Wolfram syndrome, the c.409_424dup (p.Val142Glyfs*110) is present in about 6.53% of cases (PMID:23429432).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WFS1">
              <Name>wolframin ER transmembrane glycoprotein</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_006005.3:exon 5</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="rs1362648752" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006005.3:c.409_424dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="222300" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10388078</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4041547" SubmissionDate="2022-02-10" DateLastUpdated="2022-02-11" DateCreated="2022-01-22">
        <ClinVarSubmissionID localKey="53605103|OMIM:222300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002061668" DateUpdated="2022-02-11" DateCreated="2022-01-22" Type="SCV" Version="2" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PM2, PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WFS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006005.3:c.409_424dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="222300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10978824</SubmissionName>
          <SubmissionName>SUB11067454</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5399207" SubmissionDate="2022-11-23" DateLastUpdated="2022-12-11" DateCreated="2022-12-11">
        <ClinVarSubmissionID localKey="SUB12319201" submittedAssembly="GRCh38" title="SUB12319201" />
        <ClinVarAccession Accession="SCV002605572" DateUpdated="2022-12-11" DateCreated="2022-12-11" Type="SCV" Version="1" SubmitterName="Clinical Genomics, Uppaluri K&amp;H Personalized Medicine Clinic" OrgID="508223" OrganizationCategory="clinic" OrgAbbreviation="K&amp;H CLINIC" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">22238590</ID>
          </Citation>
          <Comment>Mutations in WFS1 gene are associated with Wolfram's syndrome, an autosomal recessive condition, which cause diabetes mellitus, diabetes insipidus, deafness and optic atrophy. rs1362648752 variant is also seen in patients with Diabetes Mellitus. However, the role of this particular variant is yet to be ascertained.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">K &amp; H Uppaluri Personalized Medicine Clinic Variant Classification &amp; Assertion Criteria_Updated V.1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/var90ofb/k_h_uppaluri_personalized_medicine_clinic_variant_classification_assertion_criteria_updated_1_.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WFS1">
              <Name>wolframin ER transmembrane glycoprotein</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="rs1362648752" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.12:g.6289080_6289095dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="222300" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12319201</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3537661" SubmissionDate="2023-01-04" DateLastUpdated="2023-01-07" DateCreated="2021-08-21">
        <ClinVarSubmissionID localKey="GDXSV:254802" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001804628" DateUpdated="2023-01-07" DateCreated="2021-08-21" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Identified in 6.53% of individuals with Wolfram syndrome (de Heredia et al., 2013); This variant is associated with the following publications: (PMID: 17568405, 20738327, 34758253, 15605410, 26875006, 32179840, 32141364, 21602428, 12955714, 27395765, 11161832, 15151504, 21446023, 22238590, 15277431, 33841295, 23429432)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WFS1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:637889</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006005.3:c.409_424dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_155_20230104054205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_26_20210819132751</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3463178" TraitType="Disease" MappingType="XRef" MappingValue="125853" MappingRef="OMIM">
        <MedGen CUI="C0011860" Name="Type 2 diabetes mellitus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3110526" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3820372" TraitType="Disease" MappingType="XRef" MappingValue="222300" MappingRef="OMIM">
        <MedGen CUI="C4551693" Name="Wolfram syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3537661" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790165" TraitType="Disease" MappingType="Name" MappingValue="WFS1-Related Spectrum Disorders" MappingRef="Preferred">
        <MedGen CUI="CN239410" Name="WFS1-Related Spectrum Disorders" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4041547" TraitType="Disease" MappingType="XRef" MappingValue="222300" MappingRef="OMIM">
        <MedGen CUI="C4551693" Name="Wolfram syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5399207" TraitType="Disease" MappingType="XRef" MappingValue="222300" MappingRef="OMIM">
        <MedGen CUI="C4551693" Name="Wolfram syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24953" TraitType="Disease" MappingType="Name" MappingValue="WOLFRAM SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C4551693" Name="Wolfram syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1154433" TraitType="Disease" MappingType="Name" MappingValue="Wolfram syndrome" MappingRef="Preferred">
        <MedGen CUI="C0043207" Name="Wolfram syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

